Clinical effect of Xinmupei combined with ergometrine maleate in the treatment of postpartum hemorrhage after vaginal delivery
Objective To study the clinical effect of Xinmupei combined with ergometrine maleate in the treatment of postpartum hemorrhage after vaginal delivery.Methods 80 postpartum hemorrhage parturients who underwent vaginal delivery and divide them into a study group and a control group based on different treatment methods,with 40 cases in each group.The control group was treated with Xinmupei combined with oxytocin,while the study group was treated with Xinmupei combined with ergometrine maleate.Compare the clinical efficacy of two groups.Results The postpartum blood loss of the study group was lower than that of the control group at 2 h,12 h and 24 h(P<0.05).The incidence of adverse reactions in the study group was lower than that in the control group(P<0.05).The coagulation function of the study group was better than that of the control group(P<0.05).The stress response of the study group was lower than that of the control group(P<0.05).Conclusion The combination of Xinmupei and ergometrine maleate has a significant effect on the treatment of postpartum hemorrhage in women undergoing vaginal delivery,with fewer adverse reactions.It can also improve coagulation function and reduce maternal stress reactions,and has clinical promotion value.